Astra to pay $68.5m over drug claims

DRUGMAKER AstraZeneca has agreed to pay $68.5 million to resolve allegations by US state regulators that its marketing of the multibillion-dollar anti-psychotic drug Seroquel was deceptive.

The accord with 37 states and Washington DC is the largest multi-state, consumer protection-based pharmaceutical settlement on record.

Related topics: